FIELD: respiratory diseases. SUBSTANCE: broncholytic and antiinflammatory preparations are administered under peak-fluorometric curve control. When over one-month period, no greater than 5% approaching is registered between peak release rate before and 30 min after broncholytic administration, broncholytic preparation is cancelled. EFFECT: achieved correction of broncholytics' administration allowing treatment of patients in antiinflammatory monotherapy mode. 1 dwg
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTIC METHOD FOR BRONCHIAL ASTHMA SEVERITY | 2006 |
|
RU2348352C2 |
METHOD FOR TREATING BRONCHIAL ASTHMA IN CHILDREN IN ATTACK PERIOD | 2002 |
|
RU2236219C2 |
METHOD FOR CHRONOTHERAPY OF PATIENTS SUFFERING FROM DISSEMINATED PULMONARY TUBERCULOSIS WITH β-AGONISTS | 2004 |
|
RU2275904C1 |
METHOD FOR TREATMENT OF BRONCHIAL ASTHMA IN REMISSION PERIOD IN CHILDREN | 2004 |
|
RU2278670C2 |
METHOD OF DIAGNOSTICS OF ALLERGIC FORM OF BRONCHIAL ASTHMA IN CHILDREN UNDER 5 | 2016 |
|
RU2647195C1 |
METHOD OF TREATING BRONCHIAL ASTHMA | 2010 |
|
RU2445082C2 |
METHOD FOR TREATING THE CASES OF BRONCHIAL ASTHMA | 1999 |
|
RU2184495C2 |
METHOD FOR MAKING DIFFERENTIAL DIAGNOSIS OF CHRONIC BRONCHITIS AND BRONCHIAL ASTHMA | 1997 |
|
RU2138985C1 |
METHOD FOR SELECTING BRONCHIAL SPASMOLYTIC FOR TREATING ACUTE PERIOD OF BRONCHIAL ASTHMA IN CHILD | 2013 |
|
RU2530658C1 |
METHOD FOR TREATMENT OF SYSTEMIC AND PULMONARY ARTERIAL HYPERTENSION IN PATIENTS WITH CHRONIC OBSTRUCTIVE BRONCHITIS AND BRONCHIAL ASTHMA | 2004 |
|
RU2292889C2 |
Authors
Dates
2001-01-20—Published
1998-04-24—Filed